AKTUELLE PARTNERANGEBOTE

Risk/Benefit Analysis for the Use and Approval of Thrombolytic Antiarrhythmic and Hypolipidemic Agents

Name: Risk/Benefit Analysis for the Use and Approval of Thrombolytic Antiarrhythmic and Hypolipidemic Agents
Brand: Springer
SKU: 4443360

Risk/Benefit Analysis for the Use and Approval of Thrombolytic Antiarrhythmic and Hypolipidemic Agents. Taschenbuch. Taschenbuch

1 Angebote · ab 213,99 € gemeldete Gesamtkosten

Gute Entscheidungen beginnen mit einem guten Vergleich.